 Homepage |
 Welcome |
| Program Overview |
| Final Program Apr 23 / 24 |
| Final Program Apr 25 / 26 |
| Training Courses |
| Satellite Symposia |
| Topics |
| Posters |
| Scientific Program Structure |
| Conference Committees |
| Educational Material |
| Abstract Submission |
Continuing Medical Education |
| Registration |
| Accommodation |
| Travel Information |
| Scientific and Technical Information |
| General Information |
| Social Program |
| Patronage |
| Sponsorship & Exhibition |
| Contact Information |
 |
eurogin.com |
|
Sign up for our email mailing list to receive updates about Eurogin 2006. Your email address: |
POSTERS
Anal Neoplasia
| PO-01 | MARTINS / ORNELAS | L. | PORTUGAL | PREVALENCE OF HUMAN PAPILLOMAVIRUS DNA IN ANAL WARTS AND CARCINOMAS |
Biomarkers
| PO2-01 | FITZKY | B. | AUSTRIA | HPV E7 ONCOPROTEINS AS POTENTIAL MOLECULAR MARKER FOR CERVICAL CANCER SCREENING |
| PO2-02 | KRIVAK BOLANCA | I. | Croatia | OVEREXPRESSION OF PROTEIN p16 INK4a AS A MARKER FOR CERVICAL DYSPLASIA INDUCED BY HPV INFECTION |
Cervical Cancer
| PO3-02A | MOODLEY | M. | SOUTH AFRICA | “REDUCTION” IN PREVALENCE OF INVASIVE CERVICAL CANCER IN KWAZULU NATAL, SOUTH AFRICA: IMPACT OF THE HUMAN IMMUNODEFICIENCY VIRUS (HIV) EPIDEMIC |
| PO3-03 | PRZYBYLSKI | M. | POLAND | MARKERS OF EARLY CIN PROGRESSION |
Cervical Neoplasia
| PO4-01 | DIVANI/MARGARI | S. | GREECE | ATYPICAL ENDOCERVICAL CELLS.WHAT IS THEIR SIGNIFICANCE? |
| PO4-02 | DÖRR | A. | CZECH REPUBLIC | SENTINEL NODE DETECTION IN EARLY STAGE OF CERVICAL NEOPLASIA |
| PO4-03 | ENERSON | C. | USA | Feasibility of cryotherapy without biopsy confirmation of CIN 2 or 3 in women with two positive self-tests for high-risk human papillomavirus (HPV) and two negative acetic acid aided visual inspections (VIA) 12 months apart |
| PO4-04A | FURTADO DE MELO | Y.L. | BRAZIL | Low Grade Intraepithelial Lesion: The Colposcopic Following Importance |
| PO4-05A | KYRGIOU | M | UK | OBSTETRIC AND FERTILITY OUTCOMES AFTER CONSERVATIVE TREATMENT FOR INTRA-EPITHELIAL OR EARLY INVASIVE CERVICAL LESIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE LITERATURE |
| PO4-06 | LAI | H.C. | Taiwan | THE EXPRESSION OF DNA METHYLTRANSFEARSES IN CERVICAL NEOPLASMS AND IMPLICATIONS IN CANCER INVASION |
| PO4-07A | MADHURI | T. | UK | CARCINOMA OR METAPLASIA: A HISTOLOGICAL DILEMMA |
| PO4-09 | OSTERGARD | M. | DENMARK | LONG-TERM FOLLOW-UP ON CERVICAL SMEAR TEST IN WOMEN WITH A NEGATIVE SCREENING HISTORY |
| PO4-11 | SILVEIRA | F. | BRAZIL | Low Grade Intraepithelial Lesion: the Colposcopic Following Importance |
| PO4-12A | VLASTOS | A.T. | SWITZERLAND | CERVICAL METASTASIS OF BREAST CANCER |
Colposcopy
| PO5-02 | BEHTASH | N, | IRAN | Cervical pathology in women presenting with postcoïtal bleeding |
| PO4-04B | FURTADO DE MELO | Y.L. | BRAZIL | Margins Status after LLETZ: are there risk factors? |
| PO5-06A | NAUD | P. | BRAZIL | POSITIVE PREDICTIVE VALUE OF COLPOSCOPIC FINDINGS FOLLOWING THE INTERNATIONAL FEDERATION FOR CERVICAL PATHOLOGY AND COLPOSCOPY (IFCPC) 2002 TERMINOLOGY |
| PO5-07 | PERRINI | G. | ITALY | IS COLPOSCOPIC GRADING A PREDICTIVE FACTOR FOR HYSTOLOGICAL GRADE OF CERVICAL INTRAEPITHELIAL LESION OF LEEP SPECIMENS? |
| PO5-08 | RAY | P. | UK | PRIMARY CARE SECTOR VERSUS HOSPITAL FOLLOW-UP FOR TREATED CIN: WHICH IS THE "BEST PRACTICE" ? |
| PO5-01 | ARAFA | A. | UK | CASE CONTROL STUDY OF PREGNANCY OUTCOME AND MORBIDITY, FOLLOWING SINGLE LASER/LLETZ PROCEDURE FOR CIN PATIENTS |
| PO7-01 | BREUGELMANS | G. | FRANCE | INVASIVE CERVICAL CANCER TREATMENT COSTS IN FRANCE |
| PO7-02 | MARTIN HIRSH | P. | UK | EVALUATING MANAGEMENT PATTERNS AND ASSOCIATED COSTS OF ABNORMAL CERVICAL CYTOLOGY IN ENGLAND AND WALES |
Epidemiology
| PO8-01 | JERBI | E. | TUNISIA | HUMAN PAPILLOMAVIRUS DETECTION AND TYPING IN A TUNISIAN POPULATION USING POLYMERASE CHAIN REACTION |
| PO8-02A | KIM | C.J. | KOREA | The Clearance of Human Papillomavirus in Korean women without cervical conization |
| PO8-03 | PISTA | A. | PORTUGAL | ASSOCIATION BETWEEN p53 POLYMORPHISM AND THE RISK OF CERVICAL NEOPLASIA IN A GROUP OF PORTUGUESE WOMEN |
| PO8-04 | RAMA | C. | BRAZIL | Prevalence, Age Distribution and Risk Factors of High Risk Human Papillomavirus Infection Among Women in Brazil |
Epidemiology and Natural History
| PO5-06B | NAUD | P. | BRAZIL | THE INCIDENCE OF GENITAL HPV INFECTIONS IN SOUTH OF BRAZIL |
| PO5-06C | NAUD | P. | BRAZIL | SPONTANEOUS REGRESSION OF ASYMPTOMATIC HPV INFECTIONS IN SOUTH OF BRAZIL |
| PO9-03A | VINOKUROVA | S. | GERMANY | CLONAL HISTORY OF PAPILLOMAVIRUS-INDUCED DYSPLASIA IN THE FEMALE LOWER GENITAL TRACT |
Genital Warts
| PO10-01 | BOUCHARD | C. | CANADA | PREFERENCE FOR THE TREATMENT OF GENITAL WARTS: SURVEY OF 361 FRENCH CANADIAN WOMEN |
| PO10-02 | BOUDGHENE STAMBOULI | O. | ALGERIE | SEXUALLY TRANSMITTED DISEASES AND GENITAL WARTS. EXPERIENCE IN THE DEPARTMENT OF DERMATO-VENEREOLOGY OF TLEMCEN (Algeria) |
| PO10-03 | FORTIER | M. | CANADA | MOTIVES FOR CHOOSING IMIQUIMOD OR DESTRUCTIVE THERAPY FOR GENITAL WARTS: SURVEY OF 361 FRENCH CANADIAN WOMEN |
Genotyping
| PO11-01 | BULKMANS | N. | NETHERLANDS | HPV TYPE-SPECIFIC 18-MONTH RISK OF HIGH-GRADE CERVICAL INTRAEPITHELIAL NEOPLASIA IN WOMEN WITH A NORMAL OR BORDERLINE/MILDLY DYSKARYOTIC SMEAR |
| PO11-02A | CRICCA | M. | ITALY | ANALYSIS OF E6* SPLICED PRODUCTS OF HPV 16 AS MOLECULAR MARKERS OF CERVICAL DISEASE PROGRESSION. |
| PO11-03 | FREITAG | P. | CZECH REPUBLIC | HPV AND HLA GENOTYPING IN CERVICAL INTRAEPITHELIAL NEOPLASIA |
| PO11-04 | RODRIGUES-IGLESIAS | M. | SPAIN | COMPARISON OF THREE HYBRIDIZATION METHODS FOR THE HUMAN PAPILLOMAVIRUS GENOTYPING |
HPV testing
| PO12-01 | BAENA | J. | COLOMBIA | DETECTION OF THE ONCOGENIC HUMAN PAPILLOMAVIRUS IN WOMEN WITH A CYTOLOGICAL DIAGNOSIS OF ASCUS, USING IMMUNOHISTOCHEMESTRY IN THE "LABORATORIO CENTRAL DE CITOPATOLOGIA" IN THE JULY TO DECEMBER OF 2003 PERIOD |
| PO12-02 | CAROZZI | F. | ITALY | Analysis of Human Papillomavirus type 16 E6 variants in relation to P53 codon 72 polymorphism genotype in a group of Italian women |
| PO12-03 | CHARKVIANI / DVALISHVILI | T. | GEORGIA | Detection of human papillomavirus in endocervical glandular lesions and relationship with p53 and MIB-1 expressions |
| PO12-04 | CLAEYS | P. | BELGIUM | Prevalence of high-risk human papillomavirus types among Nicaraguan women with histological proven pre-neoplastic and neoplastic lesions of the cervix. |
| PO12-05 | COMAN | N. | ROMANIA | INCIDENCE OF HPV INFECTION IN ROAMANIA BY SFP(10)LIPA METHOD |
| PO11-02B | CRICCA | M, | ITALY | APPLICATION OF THE NASBA METHOD FOR THE DETECTION OF THE HUMAN PAPILLOMAVIRUS E6-E7 TRANSCRIPTS IN PATIENTS TREATED FOR HIGH GRADE CIN AND POSITIVE TO HPV 16 |
| PO12-07 | DERCHAIN | S. | BRAZIL | GLANDULAR CELL ABNORMALITIES IN CONVENTIONAL CERVICAL SMEARS: CYTOMORPHOLOGIC CRITERIA AND HPV TEST |
| PO12-08 | DÜRST | M. | GERMANY | RE-TESTING OF CERVICAL SCRAPES TAKEN AT BASELINE OF WOMEN WHO HAD PREVALENT OR INCIDENT CIN2, CIN3 OR CANCER (CIN2+) WITHIN 5 YEARS USING THE AMPLICOR HPV TEST |
| PO12-09 | GIRALDO | P. | BRAZIL | PROGNOSTIC MARKERS OF HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESIONS: THE ROLE OF p16INK4a AND HIGH RISK HPV |
| PO12-10 | HUANG | S.L. | TAIWAN | Comparison between the Hybrid Capture II test and a SPF1/GP6+ PCR-based assay for detection of human papillomavirus DNA in cervical swab samples |
| PO12-13 | KOLK | D. | USA | CHARACTERIZATION OF A PROTOTYPE TRANSCRIPTION-MEDIATED AMPLIFICATION BASED DIAGNOSTIC ASSAY FOR DETECTION OF HPV E6/E7 MRNA IN LBC MEDIA |
| PO12-14A | KUEVDA | D. | Russia | NOVEL HIGH-RISK HPV DNA DETECTION KIT FOR LOW-INCOME COUNTRIES |
| PO12-15 | MIZUNUMA | M. | JAPAN | HUMAN PAPPILOMAVIRUS (HPV) GENOTYPE DETECTED BY LINEAR ARRAY ASSAY IN CERVICAL SAMPLES OF JAPANESE WOMEN. |
| PO12-16 | MOCIULSCHI | R. | ROMANIA | CORRELATION BETWEEN CYTOLOGICAL ABNORMALITIES AND HPV GENOTYPES DETECTION IN THE CERVICAL LESIONS |
| PO03-02B | MOODLEY | M. | SOUTH AFRICA | THE SIGNIFICANCE OF HUMAN PAPILLOMAVIRUS INFECTION (HPV) DETECTED BY CERVICAL CYTOLOGY AMONG WOMEN INFECTED WITH THE HUMAN IMMUNODEFICIENCY VIRUS (HIV) |
| PO12-18 | MUSANTE | S. | USA | A HIGHLY SENSITIVE IN SITU HYBRIDIZATION ASSAY FOR DETECTION OF HPV IN LIQUID BASED CYTOLOGY AND CERVICAL TISSUE SAMPLES |
| PO12-20 | PRANDI | S. | ITALY | APPLICATION HPV TEST (HC2) IN MANAGEMENT OF COLPOSCOPY IN THE SCREENING PROGRAMME OF REGGIO EMILIA, ITALY |
| PO12-21 | REBELLO | G. | UK | HOW LONG DOES HPV PERSIST? |
| PO12-22 | SALFA | M.C. | ITALY | PREVALENCE AND DETERMINANTS OF HPV INFECTION AMONG ITALIAN WOMAN |
| PO12-23 | SCHALASTA | G. | GERMANY | AMPLICOR Human Papilloma Virus (HPV) Test. A comparative analysis of two different nucleic acid extraction techniques. |
| PO12-24 | SHIPITSYNA | E. | RUSSIA | TYPE-SPECIFIC PERSISTENCE OF HIGH-RISK HUMAN PAPILLOMAVIRUS DNA |
Liquid Based Cytology
| PO14-01 | ANDERSSON | S. | SWEDEN | A comparison of the liquid-based cytology and Pap smear as a second screening method for women with cytological abnormalities |
| PO14-02 | GIORGADZE | T. | USA | NUCLEAR GROOVES ARE SIGNIFICANTLY INCREASED IN BENIGN INTERMEDIATE CELLS OF HSIL CASES IN THINPREP SPECIMENS |
| PO14-03 | MARGARI | H. | GREECE | SIGNIFICANCE OF KERATINIZATION WITH ATYPIA ON ASCUS OR OTHERWISE NORMAL PAP SMEARS AS A PREDICTOR OF HUMAN PAPILLOMA VIRUS INFECTION |
| PO14-05 | NICOLL | S. | UK | IMPLEMENTATION OF THINPREP LBC IN A REGIONAL SCOTTISH LABORATORY:IMPACT ON QUALITY PARAMETERS AND LABORATORY WORKLOAD |
Management
| PO15-01A | GUEDES /BRENNA | A.C. | BRAZIL | Cost-benefits of cold-knife conization and large-loop excision at public health service in Brazil |
| PO15-01B | GUEDES /BRENNA | A.C. | BRAZIL | No treatment versus large-loop excision for CIN2 and association between p16 and its evolution |
Management of CIN
| PO16-01 | LONKY | N. | USA | Demonstration of a Novel Hemostatic Topical Agent to Control Bleeding During and Following Colposcopic Biopsy and the Loop Electrosurgical Excision Procedure (LEEP). |
Molecular Biology Carcinogenesis
| PO17-01 | BIESAGA | B. | POLAND | PROGNOSTIC SIGNIFICANCE OF HUMAN PAPILOMA VIRUS TYPE 16 AND 18 (HPV16/18) INFECTION IN RADIOTHERAPY OF CERVICAL CANCER |
Molecular Markers
| PO18-01 | KUEVDA | D. | RUSSIA | HIGH VIRAL LOAD AND INTEGRATION OF HPV16 AS MARKERS OF H-SIL AND CERVICAL CARCINOMA |
| PO18-02 | SOKOLOVA | I. | RUSSIA | Chromosome Markers for detection of HPV-associated genome instability in cervical lesions |
New Technologies
| PO04-05B | KYRGIOU | M. | UK | A SUSCEPTIBILITY-TO-CARCINOMA SPECTRAL SIGNATURE IN LIQUID BASED CYTOLOGY (LBC) USING ATTENUATED TOTAL REFLECTION FOURIER TRANSFORM INFRARED (ATR-FTIR) MICROSPECTROSCOPY: IDENTIFYING A BIOMARKER OF PROGRESSION |
Protein Vaccine
| PO20-01 | CHENG | W.F | TAIWAN | Fusion Protein Vaccine by Domains of Bacterial Exotoxin Linked with a Tumor Antigen Generates Potent Immunological Responses and Antitumor Effects |
Screening Methods
| PO21-01 | BOMFIM-HYPPOLITO | S | BRAZIL | CERVICOGRAPHY AS AN ADJUNCTIVE TEST TO VISUAL INSPECTION WITH ACETIC ACID IN CERVICAL CANCER DETECTION SCREENING |
| PO21-02 | COLLACO | L.M. | BRAZIL | THE EXPERIENCE OF CERVICAL CANCER SCREENING IN PROGRAM OF PARANÁ-BRAZIL |
| PO21-03 | FABRI | V. | BELGIUM | CERVICAL CANCER SCREENING COVERAGE IN BELGIUM |
| PO21-12 | GRANGE | G. | FRANCE | French women’s knowledge, attitudes and perceptions regarding HPV infections and cervical cancer screening |
| PO05-06D | NAUD | P. | BRAZIL | PATIENT COMPLIANCE TO CERVICAL CANCER SCREENING PROGRAM IN SOUTH OF BRAZIL |
| PO21-06 | RAMACHANDRAN | S. | USA | ALTERNATIVE TECHNOLOGIES FOR COST-EFFECTIVE HPV SCREENING IN DEVELOPING COUNTRIES |
| PO21-07 | REBOLJ | M. | NETHERLANDS | SUCCESSFUL CHANGES IN CERVICAL CANCER SCREENING IN THE NETHERLANDS |
| PO21-08 | SCHLEDERMANN | D, | DENMARK | Manual versus semi-automated screening |
| PO21-09 | SUTEU | O. | ROMANIA | STRATEGIES OF CERVICAL CANCER PREVENTION IN CLUJ COUNTY, ROMANIA |
| PO21-10 | VRDOLJAK-MOZERIC | D, | CROATIA | SCREENING PAP TEST, DIAGNOSTIC PAP TEST AND HPV TEST COMPARED TO THE HISTOLOGICAL DIAGNOSIS OF CIN2+ LESIONS |
Sexually Transmitted Infections
| PO22-01 | MAHMUDOV | F. | AZERBAIDJAN | The Evaluation of frequency of herpetic urethritis in male patients with genital herpes |
Vaginal Neoplasia
| PO4-12B | VLASTOS | A.T. | SWITZERLAND | PRIMARY MALIGNANT MELANOMA OF THE VAGINA (PMMV) |
Viral and Molecular Biology
| PO24-01 | ANTON | A.C. | ROMANIA | E-CADHERIN – MOLECULAR MARKER IN HPV CERVICAL PATHOLOGY |
| PO24-02 | JOZEFIAK | A. | POLAND | AN POLYMORPHISM IN POSTION -383 C→T IN IGF-1 P1 PROMOTER REGION DETECTED IN WOMEN HPV HIGH RISK POSITIVE |
| PO24-06 | NAGORE | N. | MEXICO | P53 AND BCL-2 PHENOTYPIC EXPRESSION, IN PRENOPLASIC AND NEOPLASIC LESIONS OF THE CERVIX |
| PO24-07 | RESSLER | S. | AUSTRIA | Expression of high-risk HPV E7 oncoproteins in cervical cancers |
| PO24-08 | TUNGSINMUNKONG | K. | THAILAND | HIGH-RISK HUMAN PAPILLOMAVIRUS AND p16INK4a PROTEIN EXPRESSION IN PRE-NEOPLASTIC AND INVASIVE CANCER OF THE CERVIX UTERI |
| PO24-09 | VERANES | E. | CUBA | COMPUTER-ANALYSIS OF TRANSCRIPTION FACTOR BINDING SITES IN LCR OF HPV 6, 11, 16, 18, 31, 39, 45, 52USING PROGRAMS BASED ON TRANSFAC® DATABASE. |
| PO9-03B | VINOKUROVA | S. | GERMANY | INTEGRATION FREQUENCY OF VIRAL GENOMES DIFFERS AMONG CERVICAL CANCERS INFECTED BY DIFFERENT HIGH RISK HPV TYPES |
Vulvar Diseases
| PO25-01 | GONTIJO | R. | BRAZIL | Human Papillomavirus (HPV) Infections as Risk Factors for Cytological and Histological Abnormalities in Baseline PAP Smear-Negative Women Followed-up for Two Years in the LAMS Study. |
| PO25-02 | HAMPL | M. | GERMANY | COMPREHENSIVE ANALYSIS OF DIFFERENT HPV TYPES IN VIN AND VULVAR CARCINOMA |
| PO25-03 | LOPES PEREIRA | M.L. | PORTUGAL | VULVAR DISEASE IN A CERVICAL DISEASE OUTPATIENT CONSULTATION: A THREE YEAR REVIEW |
| PO4-07B | MADHURI | T. | UK | VULVAL LEIOMYOSARCOMA: A RARE VARIANT |
| PO25-07 | TACHEZY | R. | CZECH REPUBLIC | THE RELATIONSHIP OF HPV TO THE PRE-MALIGNANT LESIONS AND CARCINOMA OF THE VULVA |
| PO4-12C | VLASTOS | A.T, | SWITZERLAND | OPTICAL BIOPSY OF VULVAR LESIONS |
| PO4-12D | VLASTOS / BEFFA | A.T. | SWITZERLAND | DIFFERENTIAL EXPRESSION OF MATRIX METALLOPROTEINASES 9 (MMP-9) AND CYCLINE B1 IN VULVAR INTRAEPITHELIAL NEOPLASIA (VIN) AND CARCINOMA. |